Integrated system for programmable DNA methylation

US10465187B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10465187-B2
Application numberUS-201815889368-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2018
Priority dateFeb 6, 2017
Publication dateNov 5, 2019
Grant dateNov 5, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are engineered systems and methods for establishing DNA adenine methylation at specific genomic locations and using DNA adenine methylation as an artificial chemical “handle” on the genome. These systems and methods allow for placing the handle on specific genomic locations as well as molecular technologies to bind, spatially spread, and maintain the handle. The systems described herein comprise, in some embodiments, three functional modules that mediate m6A operations: (1) a synthetic initiator module to place m6A at specific genomic sites; (2) a synthetic readout module to program m6A recognition and m6A-dependent transcriptional logic; and (3) propagation module that implements “read-write,” a mechanism proposed to underlie chromatin spreading and epigenetic maintenance across cellular systems.

First claim

Opening claim text (preview).

The invention claimed is: 1. An engineered DNA methylation system comprising: a. a reporter module comprising a nucleic acid sequence comprising one or more DNA binding domain target sites, one or more GATC nucleic acid sequences, a promoter nucleic acid sequence, and a nucleic acid sequence encoding a reporter molecule; b. a writer module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a writer fusion protein comprising: a DNA binding protein or domain thereof and a DNA adenine methyltransferase comprising the amino acid sequence of any one of SEQ ID NOs: 12-31; c. a reader-effector module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a reader-effector fusion protein comprising: a methyl-adenine DNA binding domain of DpnI endonuclease and one or more transcriptional effector domains, wherein the one or more transcriptional effector domains are repressive transcriptional domains or activating transcriptional domains; and d. a reader-writer module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a reader-writer fusion protein comprising: a DNA adenine methyltransferase comprising the amino acid sequence of any one of SEQ ID NOs: 12-31 and a methyl-adenine DNA binding domain of DpnI endonuclease. 2. An engineered DNA methylation system comprising: a. a reporter module comprising a nucleic acid sequence comprising one or more DNA binding domain target sites, one or more GATC nucleic acid sequences, a promoter nucleic acid sequence, and a nucleic acid sequence encoding a reporter molecule; b. a writer module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a writer fusion protein comprising: a DNA binding protein or domain thereof and a DNA adenine methyltransferase comprising the amino acid sequence of any one of SEQ ID NOs: 12-31, wherein the writer module binds to the one or more DNA binding domain target sites and methylates adenines (A) of the one or more GATC nucleic acid sequences of the reporter molecule, thereby initiating adenine methylation; c. a reader-effector module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a reader-effector fusion protein comprising: a methyl-adenine DNA binding domain of DpnI endonuclease and one or more transcriptional effector domains, wherein the one or more transcriptional effector domains are repressive transcriptional domains or activating transcriptional domains, and wherein the reader-effector module recognizes methylated adenines and can recruit one or more regulatory factors to the reporter molecule; and d. a reader-writer module comprising a promoter sequence operably linked to a nucleic acid sequence encoding a reader-writer fusion protein comprising: a DNA adenine methyltransferase comprising the amino acid sequence of any one of SEQ ID NOs: 12-31 and a methyl-adenine DNA binding domain of DpnI endonuclease, wherein the reader-writer fusion protein propagates the adenine methylation initiated by the writer fusion protein module. 3. The engineered DNA methylation system of claim 1 , wherein the one or more DNA binding domain target sites of the reporter module are zinc finger DNA binding domain target sites. 4. The engineered DNA methylation system of claim 3 , wherein the zinc finger DNA binding domain target site comprises SEQ ID NO: 1. 5. The engineered DNA methylation system of claim 1 , wherein the one or more DNA binding domain target sites of the reporter module are CRISPR DNA binding domain target sites. 6. The engineered DNA methylation system of claim 5 , wherein the one or more CRISPR DNA binding domain target sites comprise a sequence complementary or identical to SEQ ID NO: 36 or SEQ ID NOs: 37. 7. The engineered DNA methylation system of of claim 1 , wherein the reporter module comprises a spacer nucleic acid sequence between the one or more GATC nucleic acid sequences. 8. The engineered DNA methylation system of claim 7 , wherein the spacer sequence is at least 20 bp. 9. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the DNA adenine methyltransferase of the writer fusion protein encodes SEQ ID NO: 20. 10. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the DNA binding protein or domain thereof of the writer fusion protein encodes a zinc finger binding protein or domain thereof. 11. The engineered DNA methylation system of claim 10 , wherein the zinc finger binding protein or domain thereof comprises SEQ ID NO: 9. 12. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the DNA binding protein or domain thereof of the writer fusion protein encodes a Cas enzyme or domain thereof, and wherein the system further comprises a guide module comprising a promoter sequence operably linked to a target sequence and a sequence encoding a guide RNA. 13. The engineered DNA methylation system of claim 12 , wherein the Cas enzyme or domain thereof comprises SEQ ID NO: 10. 14. The engineered DNA methylation system of claim 12 , wherein the sequence encoding a guide RNA comprises SEQ ID NO: 45. 15. The engineered DNA methylation system of claim 12 , wherein the target sequence comprises SEQ ID NO: 36 or SEQ ID NO: 37. 16. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the writer fusion protein comprises a nuclear export signal. 17. The engineered DNA methylation system of claim 1 , wherein the writer fusion protein further comprises a linker sequence between the DNA binding protein or domain thereof and the DNA adenine methyltransferase. 18. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the methyl-adenine DNA binding domain of DpnI endonuclease of the reader-effector fusion protein encodes SEQ ID NO: 40. 19. The engineered DNA methylation system of claim 1 , wherein at least one of the one or more transcriptional effector domains of the reader-effector fusion protein is a repressive transcriptional domain. 20. The engineered DNA methylation system of claim 1 , wherein at least one of the one or more transcriptional effector domains of the reader-effector fusion protein is an activating transcriptional domain. 21. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the DNA adenine methyltransferase of the reader-writer fusion protein encodes SEQ ID NO: 20. 22. The engineered DNA methylation system of claim 1 , wherein the nucleic acid sequence encoding the methyl-adenine DNA binding domain of DpnI endonuclease of the reader-writer fusion protein encodes SEQ ID NO: 40. 23. A set of vectors or a single vector comprising the engineered DNA methylation system of claim 1 . 24. A cell comprising the engineered DNA methylation system of claim 1 . 25. The cell of claim 24 , wherein at least the reporter module of the engineered DNA methylation system is integrated at a target genomic locus of the cell. 26. The cell of claim 24 , wherein the reporter module, writer module, reader-effector module, and reader-writer module are all integrated at a target genomic locus of the cell. 27. A method of modulating the adenine methylation status of a target sequence in a cell, wherein said method comprises introducing the en

Assignees

Inventors

Classifications

  • Methyltransferases (2.1.1) · CPC title

  • Type I site-specific deoxyribonuclease (3.1.21.3) · CPC title

  • C12N15/11Primary

    DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title

  • containing a Zn-finger domain for DNA binding · CPC title

  • Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10465187B2 cover?
Provided herein are engineered systems and methods for establishing DNA adenine methylation at specific genomic locations and using DNA adenine methylation as an artificial chemical “handle” on the genome. These systems and methods allow for placing the handle on specific genomic locations as well as molecular technologies to bind, spatially spread, and maintain the handle. The systems describe…
Who is the assignee on this patent?
Univ Boston
What technology area does this patent fall under?
Primary CPC classification C12N15/11. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).